Vector administration was performed when mice were 2 months old. (a) Expression of tdTomato (red) in photoreceptors in a C57bl/6j mouse at 6 weeks after subretinal injection of 2.5×10 9 vg AAV-sgRNA. Dapi is shown in blue. (b) Immunoblot analysis of SpCas9 protein in the retinas isolated from two mice (including both genders) receiving subretinal injection of AAV-Cas9 with different doses. Vehicle injection was served as negative controls. Histone H3 was served as loading controls. (c) Immunostaining for RPE65, SOX9 or BRN3A for a male C57bl/6j mouse at 6.5 months after receiving co-administration of AAV-Cas9 and AAV-sgRNA-EGFP. Expression of tdTomato was not observed in RPE or other retinal layers. RPE, retinal pigment epithelium; OS, outer segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars: 50 μm. Each mouse received subretinal administration of the vector in one eye and vehicle in the fellow eye at 1 month of age. ERG was conducted at 4 months post treatment. The significance between the vector-and vehicle-treated eyes was calculated using two-tailed paired t-test. Five male mice were used for each dose. No significant difference (P>0.05) was observed in either dark-adapted or light-adapted ERG between the vector-and vehicle-treated eyes. 
Supplementary Figure 2. ERG analyses of C57bl/6j mice treated with AAV-Cas9 vector.
Each mouse received subretinal administration of the vector in one eye and vehicle in the fellow eye at 1 month of age. ERG was conducted at 4 months post treatment. The significance between the vector-and vehicle-treated eyes was calculated using two-tailed paired t-test. Five male mice were used for each dose. No significant difference (P>0.05) was observed in either dark-adapted or light-adapted ERG between the vector-and vehicle-treated eyes. Immunostaining for cone-specific proteins including S-opsin, cone arrestin and cone PDE. PNA staining that labels cone outer segments (OS) and inner segments (IS) was also conducted. Dapi staining is shown in blue. Scale bars, 50 μm.
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Supplementary Figure 16. ERG of Rho
-/-mice receiving AAV vector treatment. Mice received subretinal administration of vectors at P14. AAV-Cas9 (a) or AAV-sgRNA-Nrl (b) was injected to the right eyes and vehicle was injected to the left eyes. Light-adapted ERG was conducted at P90. Error bars show SEM and the significance between vector and vehicle treated eyes was calculated using two-tailed paired t-test. No significant differences (P>0.05) were observed for ERG amplitude between the right eyes and left eyes, indicating that the Cas9 vector or the sgRNA vector only could not rescue the cone function in the mice (n=6 for Cas9 vector injected mice; n=4 for sgRNA vector injected mice. Both gender of mice were used). In another cohort (same cohort as shown in Figure 5 ; n=6, recording of dark-adapted ERG from one mouse of this cohort was not conducted), mice received CRISPR-Nrl treatment in right eyes and the control CRISPR-EGFP treatment in left eyes. ERG was conducted at P70. Amplitudes of dark-adapted a wave (c) and b wave (d) are shown. Error bars show SEM and the significance between CRISPR-Nrl and CRISPR-EGFP treated eyes was calculated using twotailed paired t-test. No significant differences were observed (P>0.05). 8 (2 and 6), 1x10 9 (3 and 7) and 5x10 9 (4 and 8) vg per eye were analyzed. H3: nuclear loading control Histone H3. 
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